Authors: Legangneux, E Mora, JJ Spreux-Varoquaux, O Thorin, I Herrou, M Alvado, G Gomeni, C

Citation: E. Legangneux et al., Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [H-3]imipramine reuptake in the primary fibromyalgia syndrome, RHEUMATOLOG, 40(3), 2001, pp. 290-296

Authors: Legangneux, E McEwen, J Wesnes, KA Bergougnan, L Miget, N Canal, M L'Heritier, C Pinquier, JL Rosenzweig, P

Citation: E. Legangneux et al., The acute effects of amisulpride (50 mg and 200 mg) and haloperidol (2 mg)on cognitive function in healthy elderly volunteers, J PSYCHOPH, 14(2), 2000, pp. 164-171

Authors: Appel-Dingemanse, S Lemarechal, MO Kumle, A Hubert, M Legangneux, E

Citation: S. Appel-dingemanse et al., Integrated modelling of the clinical pharmacokinetics of SDZ HTF 919, a novel selective 5-HT4 receptor agonist, following oral and intravenous administration, BR J CL PH, 47(5), 1999, pp. 483-491

Authors: Rosenzweig, P Patat, A Curet, O Durrieu, G Dubruc, C Zieleniuk, I Legangneux, E

Citation: P. Rosenzweig et al., Clinical pharmacology of befloxatone: a brief review, J AFFECT D, 51(3), 1998, pp. 305-312